xGen™ Respiratory Virus Amplicon Panel
Integrated DNA Technologies Inc. A panel consisting of primers designed to cover >98% of the RSV A, RSV B, Influenza A H1N1, Influenza A H3N2, Influenza B, and SARS-CoV-2 genomes. These primers obtain high levels of genome coverage from as low as 10–100 viral copies. xGen Amplicon Technology uses overlapping primer sets to provide comprehensive coverage in a single-tube, 2.5-hour workflow.